SCHEMBL23559471

SCHEMBL23559471

Cc1ccc(I)cc1C(=O)OC(C)(C)C(F)(F)C(=O)O

nearest known ligand 0.35

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ NOTUM Q6P988 1/20 0.35
▸ GABRA1 P14867 1/20 0.33
▸ GABRG2 P18507 1/20 0.33
▸ GABRB3 P28472 1/20 0.33
▸ GABRA5 P31644 1/20 0.33
▸ GABRA3 P34903 1/20 0.33
▸ GABRA2 P47869 1/20 0.33
▸ CYP2C9 P11712 1/20 0.31
▸ PPARD Q03181 2/20 0.31
▸ PPARA Q07869 2/20 0.31
▸ PPARG P37231 1/20 0.31
▸ PTPRC P08575 1/20 0.31
▸ PTPN2 P17706 1/20 0.31
▸ PTPN1 P18031 1/20 0.31
▸ PTPRA P18433 1/20 0.31
▸ PTPRB P23467 1/20 0.31
▸ PTPRE P23469 1/20 0.31
▸ PTPN6 P29350 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23559314 0.86 PTPN1 (0.34) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL23559319 0.86 CA12 (0.36) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL23559561 0.84 GABRG2 (0.32) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL23559472 0.82 MAP2K1 (0.36) PPARDPPARAPPARG
SCHEMBL23559469 0.82 CES2 (0.36) NOTUMGABRA1GABRG2GABRB3GABRA5
SCHEMBL5619767 0.81 GABRG2 (0.47) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL31757283 0.81 GABRG2 (0.47) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL23559564 0.79 SOS1 (0.33) —
SCHEMBL23559559 0.78 TPMT (0.41) NOTUMPTPN2PTPN1
SCHEMBL23559473 0.78 TTR (0.39) CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210188770-A1 ONIUM SALT COMPOUND, CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2021-06-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210188770-A1 ONIUM SALT COMPOUND, CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS SLC6A5, LIFR, SLC6A9 NOTUM 576/4885GABRA1 2105/4885GABRG2 2350/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback